Back to VANGUARD GROUP INC VANGUARD GROUP INC

UNCYUNCY
3 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in UNICYCIVE THERAPEUTICS INC

As of its last 13F, for Q4 2025, Vanguard Group held 788,587 shares of UNCY (Unicycive Therapeutics), worth $4.6M. It increased the position by 129,709 shares (+19.7%) from Q3 2025. Vanguard Group held UNCY from Q2 2025 to Q4 2025, across 3 quarterly 13F filings.

Current Value

$4.6M

Current Shares

788,587

Total Value Change

+$1.7M

Total Shares Change

+182,634

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
788,587
+19.7%
$4.6M0.0%$5.59
32
2025-Q3
Increased
658,878
+8.7%
$2.9M0.0%$4.15
20
2025-Q2
New
605,953
-
$2.9M0.0%$6.80
40

Other major holders of UNCY: MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used